Hydroxyamine

Hydroxyamine

SCHEMBL19181460

NO.O=C(O)[C@]1(NS(=O)(=O)c2ccc(Oc3ccc(F)cc3)cc2)C[C@H]2CC[C@@H](C1)O2

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 18/20 0.77
MMP13 P45452 18/20 0.77
MMP2 P08253 2/20 0.77
MMP3 P08254 2/20 0.77
MMP9 P14780 2/20 0.77
MMP8 P22894 2/20 0.77
MMP12 P39900 1/20 0.53
MMP14 P50281 1/20 0.53
FFAR1 O14842 1/20 0.42
FFAR4 Q5NUL3 1/20 0.42
BCL2L1 Q07817 1/20 0.42
MCL1 Q07820 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4048453 0.98 MMP1 (0.80) MMP1MMP13MMP2MMP3MMP9
SCHEMBL7004525 0.98 MMP1 (0.80) MMP1MMP13MMP2MMP3MMP9
SCHEMBL3855639 0.88 MMP1 (0.76) MMP1MMP13MMP2MMP3MMP9
SCHEMBL6994722 0.87 MMP1 (1.00) MMP1MMP13MMP2MMP3MMP9
SCHEMBL6994719 0.87 MMP1 (1.00) MMP1MMP13MMP2MMP3MMP9
SCHEMBL6996574 0.87 MMP1 (1.00) MMP1MMP13MMP2MMP3MMP9
SCHEMBL7886290 0.84 MMP1 (0.62) MMP1MMP13MMP2MMP3MMP9
SCHEMBL6998188 0.83 MMP1 (0.71) MMP1MMP13MMP2MMP3MMP9
SCHEMBL6998192 0.83 MMP1 (0.71) MMP1MMP13MMP2MMP3MMP9
SCHEMBL7000530 0.83 MMP1 (0.70) MMP1MMP13MMP2MMP3MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10934360-B2 Human monoclonal antibodies against EPHA4 and their use THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2021-03-02 US disclosed
US-20170218075-A1 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2017-08-03 US disclosed